Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.12M | 1.01M | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.12M | 1.01M | -- | -- | -- |
| Operating Income | -1.12M | -1.01M | -- | -- | -- |
| Income Before Tax | -3.92M | -3.84M | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.92 | -3.84 | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.92M | -3.84M | -- | -- | -- |
| EBIT | -1.12M | -1.01M | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.73 | -0.74 | -- | -- | -- |
| Normalized Basic EPS | -0.11 | -0.12 | -- | -- | -- |
| EPS Diluted | -0.73 | -0.74 | -- | -- | -- |
| Normalized Diluted EPS | -0.11 | -0.12 | -- | -- | -- |
| Average Basic Shares Outstanding | 30.36M | 25.10M | -- | -- | -- |
| Average Diluted Shares Outstanding | 30.36M | 25.10M | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
